Who owns Targed?

Targed is listed as a current portfolio company of Andera Partners on Andera Partners' own portfolio page. Andera Partners has owned Targed since 2022, per Andera Partners' portfolio page.

Company Snapshot

Targed is a Biotechnology company focused on developing improved treatments for thrombotic diseases company. Its owner on record, Andera Partners, is a private equity firm. Andera Partners lists 291 companies in the index, 36 of them in Biotechnology company focused on developing improved treatments for thrombotic diseases.

About the owner

Strategy
Private Equity, Development Capital, Sponsorless Mezzanine Investment, Co-Invest, Infrastructure Investment
Sectors
Life Sciences, Biotechnologies, Mid-Caps
Companies in the index
291

Andera Partners is a private equity asset management firm that invests in companies and their management to support growth and innovation.

Read the Andera Partners profile

Questions about Targed

Who owns Targed?

Targed is listed as a current portfolio company of Andera Partners on Andera Partners' own portfolio page. Andera Partners has owned Targed since 2022, per Andera Partners' portfolio page.

What sector is Targed in?

Targed is in Biotechnology company focused on developing improved treatments for thrombotic diseases. Classified from the owner's portfolio label.

What else does Andera Partners own in Biotechnology company focused on developing improved treatments for thrombotic diseases?

Andera Partners lists 35 other Biotechnology company focused on developing improved treatments for thrombotic diseases companies in the index, including Adler Ortho, AgoMab, AM Pharma, Amolyt Pharma and Artios Pharma.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Targed and does not provide investment advice.

Other portfolio companies of Andera Partners

6 of 290 shown

See the full Andera Partners portfolio.

Other Biotechnology company focused on developing improved treatments for thrombotic diseases companies held by Andera Partners

Other Biotechnology company focused on developing improved treatments for thrombotic diseases portfolio companies

Browse PE-backed companies.